EANS-Adhoc: BWT Aktiengesellschaft
BWT takes over pharmaceutical water
business from CHRIST
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
Company Information
14.07.2009
Shareholder information Mondsee, 10th of July 2009, 8.00 am CET
BWT takes over pharmaceutical water business from CHRIST
BWT is expanding its expertise with the taking over of the pharmaceutical water activities of the Christ Water Technology Group incl. a 49% stake in zeta- group. Bringing an entirely new dimension to safety, hygiene and health in contact with life's elixir "water", in particular in pharmaceutical water applications. CHRIST has built up an excellent worldwide reputation as a pioneer in technology, European market leader and full-service provider of pharmaceutical water systems. With around 200 highly-qualified, experienced employees and annual consolidated sales of approximately 35 million Euro in this area, BWT then offers complete solutions for pure- and ultra-pure water, water for injection purposes, sterile steam, cleaning systems (CIP/SIP), pharmaceutical waste water treatment and a comprehensive range of services under the leading brand name of "Christ Aqua". Alongside its customer-focused sites in Switzerland, Germany, Sweden and Ireland, the locations in China, India and the cooperation in USA also offer BWT access to important markets outside Europe. Additionally the 49% zeta participation offers an interesting future potential in Biopharma business. The closing of the deal is expected to take place by September 30th, 2009 and is subject to the approval of the extraordinary general assembly of Christ Water Technology AG and of BWT AG in the first half of August 2009 (separate invitations will be issued soon). Additionally the approval of anti-trust agency is required. The total transaction volume incl. assets is expected to be more than 35 million EUR in cash and will be funded by existing credit lines of BWT. As a result of the sluggish overall economic performance, the takeover should have only minor effects on BWT's net profits for 2009 and 2010. Andreas Weißenbacher, "We are starting with a highly-motivated and very experienced team with the target to meet the high standards of our customers. This new line-up in the pharmaceutical water business will help us with internationalization, support our service strategies and should lead to positive contribution to net income from 2011 onwards."
Contact information: Andreas Weißenbacher, Chairman of the Board Tel. +43 (0)6232 5011 1111 Gerhard Speigner, Finance Director Tel. +43 (0)6232 5011 1112 Ralf Burchert, CEFA, Investor Relations & Corporate Communications Tel. +43 (0)6232 5011 1113, Fax +43 (0)6232 5011 1109, E-Mail: ralf.burchert@bwt.at BWT AG, A-5310 Mondsee, Walter-Simmer-Str. 4
Financial calendar:
Report 1st half year 2009 7. August 2009 Report 3rd quarter 2009 13. November 2009
BWT Company profile: The Best Water Technology Group was formed in 1990, has been listed on the
Vienna Stock Exchange since 1992 and is now Europe's leading water technology provider. Around 2,400 employees in 70 subsidiaries and associated companies are dedicated to using innovative technologies to provide customers from private households, companies and local authorities with maximum safety, hygiene and health in their daily contact with life's elixir water. BWT's shares (ISIN: AT0000737705) are listed on the Prime Market of the Vienna Stock Exchange. More at: www.bwt-group.com BWT - The Water Company
end of announcement euro adhoc
Further inquiry note:
Andreas Weißenbacher, Chairman of the Board
Tel. +43 (0)6232 5011 1111
Gerhard Speigner, Finance Director
Tel. +43 (0)6232 5011 1112
Ralf Burchert, CEFA, Investor Relations & Corporate Communications
Tel. +43 (0)6232 5011 1113, Fax +43 (0)6232 5011 1109,
E-Mail: ralf.burchert@bwt.at
BWT AG, A-5310 Mondsee, Walter-Simmer-Str. 4
Branche: Water Supply
ISIN: AT0000737705
WKN: 884042
Index: ATX Prime
Börsen: Wien / official market